An International Society for Cell and Gene Therapy Mesenchymal Stromal Cells Committee editorial on overcoming limitations in clinical trials of mesenchymal stromal cell therapy for coronavirus disease-19: time for a global registryArticle Published on 2022-11-012022-11-15 Journal: Cytotherapy [Category] 진단, [키워드] clinical trial Committee coronavirus limitation Society stromal cell therapy [DOI] 10.1016/j.jcyt.2022.07.010 PMC 바로가기
Effectiveness of COVID-19 mRNA Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance – VISION Network, 10 States, December 2021-August 2022Article Published on 2022-10-212022-11-15 Journal: Morbidity and Mortality Weekly Report [Category] COVID19(2023년), SARS, 변종, 치료제, [키워드] Against Analysis antibody antivirals B.1.1.529 benefit booster booster dose cause circulating Committee component conditions COVID-19 COVID-19 vaccination COVID-19 vaccine COVID-19 vaccines dose doses Effectiveness eligible Hospitalization Hospitalized immunocompromising condition Mask moderate molecular test mRNA network nonpharmaceutical intervention offered omicron Person positive Practice predominant Prophylactic protection Protective receive recipient recommendation recommendations reduced Restricting SARS-CoV-2 therapy vaccination Vaccine variant virus [DOI] 10.15585/mmwr.mm7142a4 PMC 바로가기
Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and WalesArticle Published on 2022-10-152022-11-16 Journal: Lancet (London, England) [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI adjusted age analyses Analysis aRR association B.1.1.529 benefit BNT162b2 booster booster dose Booster vaccine calculated ChAdOx1 nCoV-19 Chronic kidney disease Committee Comorbidities Comorbidity conducted core covariates COVID-19 COVID-19 hospitalisation COVID-19 infection COVID-19 therapeutics COVID-19 vaccination current death dominant Edinburgh England event group Health health condition high risk hospitalisation identify immunisation Immunosuppressant increased risk individual initial Innovation Ireland male Medical Research Council meta-analyses Moderna mortality data mRNA-1273 Multimorbidity National of BNT162b2 offer older adult outcome outcomes Oxford-AstraZeneca per 1000 person-year per 1000 person-years Pfizer-BioNTech Poisson regression model primary care prospective cohort prospective cohort study rate ratio receiving reduced reduced risk remained risk risk factor RT-PCR testing SARS-COV-2 infection Scottish severe COVID-19 Sex those with comorbidity university vaccination Vaccine vaccine dose vaccine group variant [DOI] 10.1016/S0140-6736(22)01656-7 PMC 바로가기
Effectiveness of a Second COVID-19 Vaccine Booster Dose Against Infection, Hospitalization, or Death Among Nursing Home Residents – 19 States, March 29-July 25, 2022Article Published on 2022-09-302022-11-16 Journal: Morbidity and Mortality Weekly Report [Category] SARS, 변종, [키워드] Against Analysis B.1.1.529 booster booster dose booster doses cause collected Committee Community COVID-19 COVID-19 infection COVID-19 vaccine death deaths dose Effectiveness Endpoint evaluated facility Follow-up home Hospitalization Immunocompromised monovalent vaccine morbidity and mortality mRNA Nursing omicron outcome outcomes Practice predominant Prevent provided resident routine care SARS-CoV-2 second severe COVID-19 vaccination Vaccine variant variants virus with COVID-19 [DOI] 10.15585/mmwr.mm7139a2 PMC 바로가기
Temporal and Spatial Cluster Analysis of 2019 Novel Coronavirus Pneumonia in Chongqing, 2020.1∼2020.2Article Published on 2022-09-162022-11-15 Journal: Computational Intelligence and Neuroscience [Category] SARS, 치료기술, [키워드] Analysis analyzed Characteristics Chongqing Cluster Committee COVID-19 COVID-19 outbreak Descriptive analysis distribution Epidemic IMPROVE incidence Novel coronavirus novel coronavirus pneumonia occurred outbreak Patient Pneumonia Prevent Region Regional risk spatiotemporal Temporal the epidemic [DOI] 10.1155/2022/8491628 PMC 바로가기
Replication of SARS-CoV-2 Omicron BA.2 variant in ex vivo cultures of the human upper and lower respiratory tractArticle Published on 2022-09-012022-11-16 Journal: EBioMedicine [Category] SARS, 변종, [키워드] airway antibody bronchial Bronchial tissue characterized China clinical manifestation Committee comparable Culture Delta delta variant disease severity Ex vivo explain explained Hong Kong human lung tissue immune evasion Infectious disease Lower respiratory tract lung lung tissue nasal nasal tissue observation omicron Omicron BA.2 parenchymal pathogenicity Patient Region replaced replicated Replication respiratory tissue SARS-CoV-2 strain Strains supported tested tissue Transmissibility Transmission university variant virus viruses wild-type wild-type virus [DOI] 10.1016/j.ebiom.2022.104232 PMC 바로가기
Consensus of the Liaison-Psychiatry Committee of the Colombian Psychiatric Association on the Diagnosis and Treatment of Delirium in the Context of the COVID-19 PandemicPractice guideline Published on 2022-09-012022-10-05 Journal: Revista Colombiana de Psiquiatría (English ed.) [Category] COVID19(2023년), SARS, 진단, 치료법, 치료제, [키워드] absence alteration Antipsychotics approach Brain Care caused Committee Consensus Context Coronavirus infection cough COVID-19 delirium Diagnosis diagnostic diagnostic techniques and procedures disease disorder Evidence Fever Health hospital Hospitalization increase increase in Infection interactions lung malaise Mental morbidity and mortality New coronavirus organ pandemic Patient pharmacological pharmacological treatment recommendation SARS-CoV-2 severe SARS-CoV-2 Side effect supported the patient Treatment treatments [DOI] 10.1016/j.rcpeng.2020.11.008 [Article Type] Practice guideline
Interim Recommendation of the Advisory Committee on Immunization Practices for Use of the Novavax COVID-19 Vaccine in Persons Aged ≥18 years – United States, July 202218세 이상인 사람의 Novavax COVID-19 백신 사용에 대한 예방접종 관행에 대한 자문 위원회의 임시 권고 - 미국, 2022년 7월Article Published on 2022-08-052022-09-11 Journal: Morbidity and Mortality Weekly Report [Category] SARS, 변종, [키워드] 95% CI Administered Adults Alpha variant assessments association authorization B.1.1.7 causal relationship cause Chain Reaction circulating Committee COVID-19 COVID-19 vaccine dose drug Efficacy efficacy analysis Emergency Emergency use authorization EUA FDA flexibility food Food and Drug Administration immunization infection with SARS-CoV-2 information Interim Matrix-M myocarditis Novavax NVX-CoV2373 per-protocol Pericarditis Person polymerase chain reaction Practice predominant PROTECT Protein provide reported reverse transcription Reverse transcription-polymerase chain reaction RT-PCR SARS-CoV-2 symptomatic symptomatic COVID-19 United States vaccination Vaccine vaccine efficacy variant virus [DOI] 10.15585/mmwr.mm7131a2 PMC 바로가기 [Article Type] Article
ESCMID COVID-19 guidelines: update on treatment for patients with mild/moderate diseaseMini review Published on 2022-08-012022-10-05 Journal: Clinical microbiology and infection : the official [Category] 임상, 치료법, 치료제, [키워드] addressed administration Antiviral antivirals approach circulating variant Committee coronavirus disease COVID-19 COVID-19 guideline death disease Disease progression epidemiological Europe healthcare Hospitalization Intervention involved mAb mAbs majority mandatory Mild Moderate COVID-19 monoclonal antibody omicron other treatment outcome Outpatient Patient performed PICO Prevent Protein question recommendation Remdesivir risk SARS-CoV-2 selected spike Treatment Vaccine variant variants of concern was used while [DOI] 10.1016/j.cmi.2022.08.013 [Article Type] Mini review
Proceedings of the Clinical Microbiology Open 2018 and 2019 – a Discussion about Emerging Trends, Challenges, and the Future of Clinical Microbiology임상 미생물학 공개 2018 및 2019의 회보 - 임상 미생물학의 새로운 추세, 도전 과제 및 미래에 대한 토론Review Published on 2022-07-202022-09-12 Journal: Journal of Clinical Microbiology [Category] MERS, 진단, [키워드] agency clinical Collaborative effort Committee Community coronavirus disease Council COVID COVID-19 COVID-19 pandemic Critical diagnostic diagnostics expand Future Laboratory Microbiology molecular Next-generation sequencing organizations pandemic Pandemics Planning platform POCT point of care point of care testing Proceeding provide Public resource resources respond Society staffing stewardship supported susceptibility unique utilization [DOI] 10.1128/jcm.00092-22 PMC 바로가기 [Article Type] Review